Interfering Residues Narrow the Spectrum of MLV Restriction by Human TRIM5α
暂无分享,去创建一个
D. Trono | P. Maillard | P. Turelli | F. Serhan | S. Reynard
[1] J. Sodroski,et al. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction. , 2007, Virology.
[2] M. Emerman,et al. Restriction of an Extinct Retrovirus by the Human TRIM5α Antiviral Protein , 2007, Science.
[3] J. Trowsdale,et al. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function , 2007, Proceedings of the National Academy of Sciences.
[4] M. Emerman,et al. Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein. , 2007, Science.
[5] M. Yap,et al. All Three Variable Regions of the TRIM5α B30.2 Domain Can Contribute to the Specificity of Retrovirus Restriction , 2006, Journal of Virology.
[6] J. Sodroski,et al. Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1. , 2006, Virology.
[7] Joseph Sodroski,et al. Removal of Arginine 332 Allows Human TRIM5α To Bind Human Immunodeficiency Virus Capsids and To Restrict Infection , 2006, Journal of Virology.
[8] J. Sodroski,et al. Two Surface-Exposed Elements of the B30.2/SPRY Domain as Potency Determinants of N-Tropic Murine Leukemia Virus Restriction by Human TRIM5α , 2006, Journal of Virology.
[9] G. Towers,et al. Cyclophilin A Renders Human Immunodeficiency Virus Type 1 Sensitive to Old World Monkey but Not Human TRIM5α Antiviral Activity , 2006, Journal of Virology.
[10] Joseph Sodroski,et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[11] B. Oh,et al. Structural and functional insights into the B30.2/SPRY domain , 2006, The EMBO journal.
[12] J. Luban,et al. Cyclophilin A and TRIM5α Independently Regulate Human Immunodeficiency Virus Type 1 Infectivity in Human Cells , 2006, Journal of Virology.
[13] J. Tschopp,et al. Structure of the PRYSPRY‐domain: Implications for autoinflammatory diseases , 2006, FEBS letters.
[14] B. de Bono,et al. Relationship between SPRY and B30.2 protein domains. Evolution of a component of immune defence? , 2005, Immunology.
[15] A. Yang,et al. Human Tripartite Motif 5α Domains Responsible for Retrovirus Restriction Activity and Specificity , 2005, Journal of Virology.
[16] J. Luban,et al. TRIM5α selectively binds a restriction-sensitive retroviral capsid , 2005, Retrovirology.
[17] J. Sodroski,et al. The B30.2(SPRY) Domain of the Retroviral Restriction Factor TRIM5α Exhibits Lineage-Specific Length and Sequence Variation in Primates , 2005, Journal of Virology.
[18] M. Sitbon,et al. Residues in the Murine Leukemia Virus Capsid That Differentially Govern Resistance to Mouse Fv1 and Human Ref1 Restrictions , 2005, Journal of Virology.
[19] J. Sodroski,et al. Retrovirus Restriction by TRIM5α Variants from Old World and New World Primates , 2005, Journal of Virology.
[20] J. Sodroski,et al. Species-Specific Variation in the B30.2(SPRY) Domain of TRIM5α Determines the Potency of Human Immunodeficiency Virus Restriction , 2005, Journal of Virology.
[21] Jonathan P. Stoye,et al. A Single Amino Acid Change in the SPRY Domain of Human Trim5α Leads to HIV-1 Restriction , 2005, Current Biology.
[22] J. Sodroski,et al. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. , 2005, Journal of virology.
[23] P. Bieniasz. Intrinsic immunity: a front-line defense against viral attack , 2004, Nature Immunology.
[24] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[25] I. Taylor,et al. High-resolution structure of a retroviral capsid hexameric amino-terminal domain , 2004, Nature.
[26] M. Bock,et al. Retroviral Capsid Determinants of Fv1 NB and NR Tropism , 2004, Journal of Virology.
[27] J. Sodroski,et al. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Nisole,et al. Trim5α protein restricts both HIV-1 and murine leukemia virus , 2004 .
[29] G. Towers,et al. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. Yang,et al. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. M. Owens,et al. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.
[32] S. Nisole,et al. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[33] S. Goff,et al. Characterization of Murine Leukemia Virus Restriction in Mammals , 2003 .
[34] G. Towers,et al. Identification of the Regions of Fv1 Necessary for Murine Leukemia Virus Restriction , 2001, Journal of Virology.
[35] Alessandro Guffanti,et al. The tripartite motif family identifies cell compartments , 2001, The EMBO journal.
[36] Y. Takeuchi,et al. A conserved mechanism of retrovirus restriction in mammals. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[37] G. Towers,et al. Use of a Transient Assay for Studying the Genetic Determinants of Fv1 Restriction , 2000, Journal of Virology.
[38] C. Kozak,et al. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance. , 1996, Virology.
[39] Jonathan P. Stoye,et al. Positional cloning of the mouse retrovirus restriction gene Fvl , 1996, Nature.
[40] Wesley I. Sundquist,et al. Structure of the Amino-Terminal Core Domain of the HIV-1 Capsid Protein , 1996, Science.
[41] P. Freemont,et al. Novel topology of a zinc‐binding domain from a protein involved in regulating early Xenopus development. , 1995, The EMBO journal.
[42] P. Freemont,et al. A novel zinc finger coiled-coil domain in a family of nuclear proteins. , 1992, Trends in biochemical sciences.
[43] R. Tennant,et al. Nucleotide sequences of gag-pol regions that determine the Fv-1 host range property of BALB/c N-tropic and B-tropic murine leukemia viruses , 1983, Journal of virology.
[44] P. Jolicoeur,et al. Physical mapping of the Fv-1 tropism host range determinant of BALB/c murine leukemia viruses , 1983, Journal of virology.
[45] E. Rassart,et al. Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus , 1980, Journal of virology.
[46] F. Lilly. Susceptibility to Two Strains of Friend Leukemia Virus in Mice , 1967, Science.